We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
Cap. Flow
-$209M
Cap. Flow %
-30.05%
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257

Top Buys

Rank Stock Value
1
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$2.36M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.32M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.29M
4
HSII
Heidrick & Struggles
HSII
+$2.25M
5
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
+$2.17M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$5.99M
2
CMC icon
Commercial Metals
CMC
+$5.95M
3
BHE icon
Benchmark Electronics
BHE
+$5.84M
4
UPBD icon
Upbound Group
UPBD
+$5.71M
5
RAIL icon
FreightCar America
RAIL
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 18.04%
2 Industrials 15.17%
3 Technology 12.86%
4 Consumer Discretionary 12.11%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNDA icon
1101
Vanda Pharmaceuticals
VNDA
$312M
– –
-77,342
Closed -$720K
VRE
1102
DELISTED
Veris Residential
VRE
– –
-16,707
Closed -$390K
WSBF icon
1103
Waterstone Financial
WSBF
$362M
– –
-34,380
Closed -$485K
WYY icon
1104
WidePoint Corp
WYY
$104M
– –
-2,979
Closed -$21K
ZWS icon
1105
Zurn Elkay Water Solutions
ZWS
$8.07B
– –
-70,702
Closed -$617K
TXNM
1106
TXNM Energy Inc
TXNM
$6.47B
– –
-12,612
Closed -$386K
INVX
1107
Innovex International
INVX
$1.87B
– –
-27,950
Closed -$1.66M
PVLA
1108
Palvella Therapeutics
PVLA
$1.98B
– –
-295
Closed -$54K
NPKI
1109
NPK International
NPKI
$1.21B
– –
-28,410
Closed -$150K
TPC
1110
Tutor Perini Cor
TPC
$4.57B
– –
-107,322
Closed -$1.8M
RVNC
1111
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-29,460
Closed -$1.01M
CDMO
1112
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-10,358
Closed -$85K
B
1113
DELISTED
Barnes Group Inc.
B
– –
-30,950
Closed -$1.09M
PRMW
1114
DELISTED
Primo Water Corporation
PRMW
– –
-10,067
Closed -$111K
ALIM
1115
DELISTED
Alimera Sciences
ALIM
– –
-894
Closed -$32K
ASXC
1116
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-3,593
Closed -$116K
TCON
1117
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
– –
-52
Closed -$96K
MRNS
1118
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-2,537
Closed -$78K
FIF
1119
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
– –
-31,761
Closed -$463K
EIGR
1120
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-63
Closed -$41K
CPE
1121
DELISTED
Callon Petroleum Company
CPE
– –
-2,776
Closed -$232K
SIEN
1122
DELISTED
Sientra, Inc.
SIEN
– –
-1,271
Closed -$75K
IMGN
1123
DELISTED
Immunogen Inc
IMGN
– –
-97,566
Closed -$1.32M
NVTA
1124
DELISTED
Invitae Corporation
NVTA
– –
-51,190
Closed -$420K
CHS
1125
DELISTED
Chicos FAS, Inc.
CHS
– –
-23,500
Closed -$251K
43 44
45
46 47

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q1 2016 Portfolio in Review

As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.

  • TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
  • TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
  • TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
  • TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
  • TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
  • TFS Capital opened 502 new positions and closed 257 in Q1 2016.
  • TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.